| Clinical diagnosis of gastrointestinal stromal tumor (GIST): from the molecular genetic point of view CE Wu, CY Tzen, SY Wang, CN Yeh Cancers 11 (5), 679, 2019 | 108 | 2019 |
| ALDH1A3, the major aldehyde dehydrogenase isoform in human cholangiocarcinoma cells, affects prognosis and gemcitabine resistance in cholangiocarcinoma patients MH Chen, JJ Weng, CT Cheng, RC Wu, SC Huang, CE Wu, YH Chung, ... Clinical Cancer Research 22 (16), 4225-4235, 2016 | 57 | 2016 |
| Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma CE Wu, A Esfandiari, YH Ho, N Wang, AK Mahdi, E Aptullahoglu, P Lovat, ... British journal of cancer 118 (4), 495-508, 2018 | 55 | 2018 |
| Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms JWC Chang, NC Wei, HJ Su, JL Huang, TC Chen, YC Wu, CT Yu, ... Anticancer research 32 (4), 1259-1265, 2012 | 52 | 2012 |
| PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy KT Tan, CN Yeh, YC Chang, JH Cheng, WL Fang, YC Yeh, YC Wang, ... Journal for immunotherapy of cancer 8 (1), 2020 | 42 | 2020 |
| Circulating tumour cells as an independent prognostic factor in patients with advanced oesophageal squamous cell carcinoma undergoing chemoradiotherapy PJ Su, MH Wu, HM Wang, CL Lee, WK Huang, CE Wu, HK Chang, ... Scientific Reports 6 (1), 31423, 2016 | 38 | 2016 |
| Prospective evaluation of neoadjuvant imatinib use in locally advanced gastrointestinal stromal tumors: emphasis on the optimal duration of neoadjuvant imatinib use, safety … SY Wang, CE Wu, CC Lai, JS Chen, CY Tsai, CT Cheng, TS Yeh, CN Yeh Cancers 11 (3), 424, 2019 | 32 | 2019 |
| A prognostic model based on circulating tumour cells is useful for identifying the poorest survival outcome in patients with metastatic colorectal cancer WC Chou, MH Wu, PH Chang, HC Hsu, G Chang, WK Huang, CE Wu, ... International journal of biological sciences 14 (2), 137, 2018 | 32 | 2018 |
| Prevalence of severe depressive symptoms increases as death approaches and is associated with disease burden, tangible social support, and high self-perceived burden to others ST Tang, JS Chen, WC Chou, KC Lin, WC Chang, CH Hsieh, CE Wu Supportive Care in Cancer 24, 83-91, 2016 | 29 | 2016 |
| Changes in and modifiable patient‐and family caregiver‐related factors associated with cancer patients’ high self‐perceived burden to others at the end of life: A longitudinal … SC Kuo, WC Chou, MM Hou, CE Wu, WC Shen, FH Wen, ST Tang European journal of cancer care 27 (6), e12942, 2018 | 27 | 2018 |
| Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients CC Hsu, CE Wu, JS Chen, JH Tseng, KC Chiang, YY Liu, CY Tsai, ... Anticancer research 34 (9), 5029-5036, 2014 | 25 | 2014 |
| The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies CE Wu, CK Yang, MT Peng, PW Huang, CF Chang, KY Yeh, CB Chen, ... BMC cancer 20, 1-12, 2020 | 24 | 2020 |
| Targeting P53 as a future strategy to overcome gemcitabine resistance in biliary tract cancers CE Wu, YR Pan, CN Yeh, J Lunec Biomolecules 10 (11), 1474, 2020 | 24 | 2020 |
| Longitudinal analysis of severe anxiety symptoms in the last year of life among patients with advanced cancer: relationships with proximity to death, burden, and social support ST Tang, JS Chen, WC Chou, WC Chang, CE Wu, CH Hsieh, MC Chiang, ... Journal of the National Comprehensive Cancer Network 14 (6), 727-734, 2016 | 24 | 2016 |
| ATM dependent DUSP6 modulation of p53 involved in synergistic targeting of MAPK and p53 pathways with trametinib and MDM2 inhibitors in cutaneous melanoma CE Wu, TS Koay, A Esfandiari, YH Ho, P Lovat, J Lunec Cancers 11 (1), 3, 2018 | 23 | 2018 |
| Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world … CE Wu, WC Chou, CH Hsieh, JWC Chang, CY Lin, CN Yeh, JS Chen BMC cancer 20, 1-12, 2020 | 21 | 2020 |
| A nomogram predicting progression free survival in patients with gastrointestinal stromal tumor receiving sunitinib: incorporating pre-treatment and post-treatment parameters YR Chang, WK Huang, SY Wang, CE Wu, JS Chen, CN Yeh Cancers 13 (11), 2587, 2021 | 18 | 2021 |
| Using aprepitant as secondary antiemetic prophylaxis for cancer patients with cisplatin-induced emesis CE Wu, CC Liaw Supportive Care in Cancer 20, 2357-2361, 2012 | 18 | 2012 |
| Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study CE Wu, CF Chang, CY Huang, CT Yang, CHS Kuo, PC Hsu, JWC Chang BMC cancer 21, 1-14, 2021 | 17 | 2021 |
| Immune checkpoint inhibitors for advanced melanoma: experience at a single institution in Taiwan CE Wu, CK Yang, MT Peng, PW Huang, YF Lin, CY Cheng, YY Chang, ... Frontiers in Oncology 10, 905, 2020 | 16 | 2020 |
Wen-Kuan HuangAssistant professor, Chang Gung Memorial Hospital, Linkou, Taiwan; Department Onco-Path, KarolinskaVerified email at ki.se
